After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower_老虎社区_美港股上老虎

After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower

StreetInsider2022-01-19

After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

happymoney
·2022-01-19
High high
回复
1
举报
收起
- happymoney:
  In the sky
  2022-01-19
  回复
  举报
happymoney
·2022-01-19
Fififinally
回复
点赞
举报
Alan_Goh
·2022-01-19
I am super delighted :) :) !!
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1116383287?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-01-19 07:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116383287","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19473116\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19473116><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19473116\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TGNA","symbol_name":"Tegna Inc","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=19473116","article_id":"1116383287","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116383287","pubTimestamp":1642548344,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TGNA":"Tegna Inc","CRDF":"Cardiff Oncology, Inc.","CNXC":"Concentrix Corp","VERO":"Venus Concept Inc.","SOFI":"SoFi Technologies Inc.","RVNC":"Revance Therapeutics Inc"},"translate_title":"盘后股票市场：索菲、康森特里克斯、泰格纳走高；卡迪夫，广告更低","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADS":0.9,"CNXC":0.9,"CRDF":0.9,"RVNC":0.9,"SOFI":0.9,"TGNA":0.9,"VERO":0.9},"content_text":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.ADS (NYSE: ADS) 5.9% LOWER; BJ's Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJConcentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.Venus Concept Inc. (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":697439239,"gmtCreate":1642554816719,"gmtModify":1642554817127,"author":{"id":"3569807126010989","authorId":"3569807126010989","name":"happymoney","avatar":"https://static.tigerbbs.com/c7b835f693b89bd9b980cc013a40c669","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3569807126010989","authorIdStr":"3569807126010989"},"htmlText":"High high","listText":"High high","text":"High high","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/697439239","repostId":1116383287,"repostType":2,"repost":{"id":"1116383287","pubTimestamp":1642548344,"share":"https://www.laohu8.com/m/news/1116383287?lang=&edition=full","pubTime":"2022-01-19 07:25","market":"us","language":"en","title":"After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=1116383287","media":"StreetInsider","summary":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from ","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/CRDF\">Cardiff Oncology, Inc.</a> (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.</p><p>SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.</p><p>ADS (NYSE: ADS) 5.9% LOWER; BJ&#39;s Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJ</p><p>Concentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.</p><p>TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).</p><p>Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.</p><p><a href=\"https://laohu8.com/S/VERO\">Venus Concept Inc.</a> (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19473116><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19473116\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGNA":"Tegna Inc","RVNC":"Revance Therapeutics Inc","SOFI":"SoFi Technologies Inc.","CRDF":"Cardiff Oncology, Inc.","CNXC":"Concentrix Corp","VERO":"Venus Concept Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19473116","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116383287","content_text":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.ADS (NYSE: ADS) 5.9% LOWER; BJ's Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJConcentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.Venus Concept Inc. (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7190163,"gmtCreate":1642554830041,"gmtModify":1642554830126,"authorId":3569807126010989,"author":{"id":3569807126010989,"idStr":"3569807126010989","authorId":3569807126010989,"name":"happymoney","avatar":"https://static.tigerbbs.com/c7b835f693b89bd9b980cc013a40c669","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":697439239,"type":1,"supId":0,"prevId":0,"content":"In the <u>sky</u>","text":"In the <u>sky</u>","html":"In the <u>sky</u>"}],"langContent":"CN"},{"id":697439861,"gmtCreate":1642554796920,"gmtModify":1642554797385,"author":{"id":"3569807126010989","authorId":"3569807126010989","name":"happymoney","avatar":"https://static.tigerbbs.com/c7b835f693b89bd9b980cc013a40c669","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3569807126010989","authorIdStr":"3569807126010989"},"htmlText":"Fififinally","listText":"Fififinally","text":"Fififinally","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697439861","repostId":1116383287,"repostType":2,"repost":{"id":"1116383287","pubTimestamp":1642548344,"share":"https://www.laohu8.com/m/news/1116383287?lang=&edition=full","pubTime":"2022-01-19 07:25","market":"us","language":"en","title":"After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=1116383287","media":"StreetInsider","summary":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from ","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/CRDF\">Cardiff Oncology, Inc.</a> (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.</p><p>SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.</p><p>ADS (NYSE: ADS) 5.9% LOWER; BJ&#39;s Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJ</p><p>Concentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.</p><p>TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).</p><p>Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.</p><p><a href=\"https://laohu8.com/S/VERO\">Venus Concept Inc.</a> (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19473116><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19473116\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGNA":"Tegna Inc","RVNC":"Revance Therapeutics Inc","SOFI":"SoFi Technologies Inc.","CRDF":"Cardiff Oncology, Inc.","CNXC":"Concentrix Corp","VERO":"Venus Concept Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19473116","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116383287","content_text":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.ADS (NYSE: ADS) 5.9% LOWER; BJ's Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJConcentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.Venus Concept Inc. (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":697405224,"gmtCreate":1642551435965,"gmtModify":1642551436167,"author":{"id":"3570187411453325","authorId":"3570187411453325","name":"Alan_Goh","avatar":"https://static.tigerbbs.com/de7c3c15ca8d800dc8cfed7fb85ee1b3","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3570187411453325","authorIdStr":"3570187411453325"},"htmlText":"I am super delighted :) :) !!","listText":"I am super delighted :) :) !!","text":"I am super delighted :) :) !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697405224","repostId":1116383287,"repostType":2,"repost":{"id":"1116383287","pubTimestamp":1642548344,"share":"https://www.laohu8.com/m/news/1116383287?lang=&edition=full","pubTime":"2022-01-19 07:25","market":"us","language":"en","title":"After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=1116383287","media":"StreetInsider","summary":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from ","content":"<html><head></head><body><p>After-Hours Stock Movers:</p><p><a href=\"https://laohu8.com/S/CRDF\">Cardiff Oncology, Inc.</a> (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.</p><p>SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.</p><p>ADS (NYSE: ADS) 5.9% LOWER; BJ&#39;s Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJ</p><p>Concentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.</p><p>TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).</p><p>Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.</p><p><a href=\"https://laohu8.com/S/VERO\">Venus Concept Inc.</a> (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: SoFi,Concentrix,TEGNA Higher; Cardiff,ADS Lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19473116><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19473116\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGNA":"Tegna Inc","RVNC":"Revance Therapeutics Inc","SOFI":"SoFi Technologies Inc.","CRDF":"Cardiff Oncology, Inc.","CNXC":"Concentrix Corp","VERO":"Venus Concept Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19473116","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116383287","content_text":"After-Hours Stock Movers:Cardiff Oncology, Inc. (Nasdaq: CRDF) 16.6% LOWER; announced new data from its lead clinical program evaluating onvansertib in combination with standard-of-care (SOC) FOLFIRI/bevacizumab for second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC). A subset of these data will be featured in a poster presented by Dr. Heinz-Josef Lenz, principal investigator, USC Norris Comprehensive Cancer Center, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCOGI) on Saturday, January 22, 2022.SoFi Technologies, Inc. (NASDAQ: SOFI) 10.8% HIGHER; The Office of the Comptroller of the Currency (OCC) today conditionally approved applications from Social Finance Inc. (SoFi) (NASDAQ: SOFI) to create SoFi Bank, National Association (SoFi Bank, N.A.), as a full service national bank headquartered in Cottonwood Heights, Utah. As part of the transaction, SoFi Bank, N.A. will acquire Golden Pacific Bank, National Association, a national bank insured by the Federal Deposit Insurance Corporation.ADS (NYSE: ADS) 5.9% LOWER; BJ's Wholesale Club (NYSE: BJ) Moving Co-Branded Credit Cards to Capital One (NYSE: COF) in Blow to ADS (NYSE: ADS) - WSJConcentrix Corporation (NASDAQ: CNXC) 5% HIGHER; reported Q4 EPS of $2.99, $0.28 better than the analyst estimate of $2.71. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion. Concentrix Corporation sees FY2022 revenue of $6.45-6.6 billion, versus the consensus of $6.16 billion.TEGNA (NYSE: TGNA) 4.3% HIGHER; Standard General, Apollo Global (NYSE: APO) Close in on $9B Deal for TEGNA (NYSE: TGNA).Revance Therapeutics, Inc. (Nasdaq: RVNC) 4.2% HIGHER; received the official Type A meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for DaxibotulinumtoxinA for Injection for glabellar lines. The Type A meeting was held on December 15, 2021.Venus Concept Inc. (NASDAQ: VERO 2.3% HIGHER; received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":34,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}